Addiction & Substance Use

Novel treatment for cocaine use disorder? Researchers performed a randomized, double-blind, placebo-controlled trial of lorcaserin.

This book seeks to reduce the stigma surrounding teen pregnancy.

Learn more about the latest viral substance abuse trend.

Enter your email to check out this complicated case!

In this CME article, learn how best to provide end-of-life care to patients with psychiatric disorders.

Assisted outpatient treatment is not intended to replace comprehensive, easy-to-access, voluntary treatment. Here's why we need it, according to one expert.

Learn more about the latest research related to 9/11 trauma and other psychiatric comorbidities.

When psychiatrists fully embrace psychopharmacological interventions as integral components of addiction treatment, patients can begin a journey toward sustainable recovery.

Tomorrow, August 31, is Overdose Awareness Day. What can you be doing to help prevent overdose deaths?

In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.

Cannabis use during adolescence can profoundly impact brain development.

Social media is here to stay, and its use must be a consideration in the treatment of psychiatric conditions, particularly substance use disorder and alcohol use disorder.

Learn more about cannabis use and social media addiction in this month's Special Report!

What influence do legislation and social-based decisions have on individual mental health, like in the case of drag performers?

Guidelines from the World Health Organization's Mental Health Gap Action Program support nonspecialist health workers providing evidence-based treatments in underresourced regions.

The FDA has issued a complete response letter to Orexo for OX124, a high-dose naloxone nasal spray for opioid overdose reversal.

What is new in research on alcohol use disorder?

To expertly utilize polypharmacy, it is imperative that clinicians stay abreast of new literature, check for drug-drug interactions, and be aware of emerging trends in drug use.

Inhalant use disorder is characterized by the intentional inhalation of volatile substances for their psychoactive effects. Learn more about how to help manage this disorder.

An expert discusses this comorbidity, plus the effects of semaglutide and other GLP-1 agonists on this patient population.

The FDA has authorized the marketing of 4 menthol-flavored e-cigarette products in the United States through the premarket tobacco product application pathway.

Cannabis withdrawal syndrome impacts approximately half of those who use it regularly. How can you help patients cease cannabis use?

Review tapering challenges and strategies for benzodiazepines in this Special Report article.

With cannabis legalization increasing in the United States, so too are the issues surrounding cannabis access, usage, and use disorders. State by state, take a peek at some of the issues and updates surrounding cannabis.

Here are highlights from the week in Psychiatric Times.